Otros idiomas Aurisco Pharmaceutical Co.,Ltd.

Acciones

605116

CNE1000042S4

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
24,89 ^CNY	+1,97 %		+0,53 %	-3,60 %

28/04	Aurisco Pharmaceutical Co.,Ltd. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
2023	Aurisco Pharmaceutical Co.,Ltd. informa de los resultados de los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Certain A Shares of Aurisco Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-SEP-2023.	21/09/23
Aurisco Pharmaceutical Co.,Ltd.(XSSC:605116) added to S&P Global BMI Index	18/09/23
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Aurisco Pharmaceutical Gets Auxiton(R) (Dydrogesterone) as First Generic Approval in China	27/06/23
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
Aurisco Cooperates with Cytiva to Build Its First Oligo Flexfactory for Commercial Production	05/01/23
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Certain A Shares of Aurisco Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-SEP-2022.	21/09/22
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/04/22
Huayi Boao Quantum Technology Co., Ltd. announced that it has received CNY 100 million in funding from Aurisco Pharmaceutical Co.,Ltd., Gaorong Capital, Sequoia China Investment Management LLP, Turing Ventures, Qiji Chuangtan Investment Management Co., Ltd.	22/04/22
Huayi Quantum announced that it has received CNY 15.5 million in funding from Gaorong Capital, Sequoia China Investment Management LLP, Qiji Chuangtan Investment Management Co., Ltd., Turing Ventures, Aurisco Pharmaceutical Co.,Ltd.	22/04/22
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
Certain A Shares of Aurisco Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-SEP-2021.	21/09/21
Aurisco Pharmaceutical Co.,Ltd.(SHSE:605116) added to Shanghai Stock Exchange A Share Index	20/09/21
Aurisco Pharmaceutical Co.,Ltd.(SHSE:605116) added to Shanghai Stock Exchange Composite Index	20/09/21
Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Aurisco Pharmaceutical Co.,Ltd.

Acciones

605116

CNE1000042S4

Otros idiomas

Filtros